References
- Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol. 2011;7:639–49.
- Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature 2016;539:197–206.
- Andersen PM. Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene. Curr Neurol Neurosci Rep. 2006;6:37–46.
- Majounie E, Renton AE, Mok K, Dopper EGP, Waite A, Rollinson S, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. ITALSGEN Consortium 2012;11:323–04.
- Shepheard SR, Parker MD, Cooper-Knock J, Verber NS, Tuddenham L, Heath P, et al. Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. Project MinE 2021; 92:510–8.
- Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology 2006;66:265–7.
- Hand CK, Mayeux-Portas V, Khoris J, Briolotti V, Clavelou P, Camu W, et al. Compound heterozygous D90A and D96N SOD1 mutations in a recessive amyotrophic lateral sclerosis family. Ann Neurol. 2001;49:267–71.
- Brown JA, Min J, Staropoli JF, Collin E, Bi S, Feng X, et al. SOD1, ANG, TARDBP and FUS mutations in amyotrophic lateral sclerosis: a United States clinical testing lab experience. Amyotroph Lateral Scler. 2012;13:217–22.
- Kuuluvainen L, Kaivola K, Mönkäre S, Laaksovirta H, Jokela M, Udd B, et al. Oligogenic basis of sporadic ALS: The example of SOD1 p.Ala90Val mutation. Neurol Genet. 2019;5:e335.
- Keckarević D, Stević Z, Keckarević-Marković M, Kecmanović M, Romac S. A novel P66S mutation in exon 3 of the SOD1 gene with early onset and rapid progression. Amyotroph Lateral Scler. 2012;13:237–40.
- Baek W, Koh S-H, Kim YS, Kim HY, Kwon M-J, Ki C-S, et al. A novel exon 3 mutation (P66S) in the SOD1 gene in familial ALS. Can J Neurol Sci. 2012;39:245–6.
- Kwon M-J, Baek W, Ki C-S, Kim HY, Koh S-H, Kim J-W, et al. Screening of the SOD1, FUS, TARDBP, ANG, and OPTN mutations in Korean patients with familial and sporadic ALS. Neurobiol Aging. 2012;33:1017.e17–1017.e23.
- Wei Q, Zhou Q, Chen Y, Ou RWei, Cao B, Xu Y, et al. Analysis of SOD1 mutations in a Chinese population with amyotrophic lateral sclerosis: a case-control study and literature review. Sci Rep. 2017;7:44606.
- Tang L, Ma Y, Liu XL, Chen L, Fan DS. Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history. Transl Neurodegener. 2019;8:2.
- Bernard E, Pegat A, Svahn J, Bouhour F, Leblanc P, Millecamps S, et al. Clinical and molecular landscape of ALS patients with SOD1 mutations: novel pathogenic variants and novel phenotypes. a single ALS center study. 2020;21:6807.
- Chen W, Xie Y, Zheng M, Lin J, Huang P, Pei Z, et al. Clinical and genetic features of patients with amyotrophic lateral sclerosis in southern China. Eur J Neurol. 2020;27:1017–22.
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. ACMG Laboratory Quality Assurance Committee 2015;17:405–24.
- Al-Chalabi A, Andersen PM, Chioza B, Shaw C, Sham PC, Robberecht W, et al. Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum Mol Genet. 1998;7:2045–50.
- Shibuya K, Sawai S, Sugiyama A, et al. Facial onset amyotrophic lateral sclerosis with K3E variant in the Cu/Zn superoxide dismutase gene. Amyotroph Lateral Scler Frontotemporal Degener 2020;30:1–3.
- Mizuno M, Ueki Y, Sakurai K, Okita K, Endo F, Yamanaka K, et al. Case of familial amyotrophic lateral sclerosis showing gadolinium-enhanced cranial nerves on magnetic resonance imaging associated with rapid progression of facial nerve palsy. Neurol Clin Neurosci. 2014;2:54–6.
- Salameh JS, Atassi N, David WS. SOD1 (A4V)-mediated ALS presenting with lower motor neuron facial diplegia and unilateral vocal cord paralysis. Muscle Nerve. 2009;40:880–2.
- Broad R, Leigh PN. Recognising facial onset sensory motor neuronopathy syndrome: insight from six new cases. Pract Neurol. 2015;15:293–7.